🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/08/1997 | 44,85 | 45,24 | 44,49 | 45,21 | +1,61% | 1,66% | 7.574.315 |
| 18/08/1997 | 43,57 | 44,55 | 43,42 | 44,49 | +2,61% | 2,60% | 8.919.109 |
| 15/08/1997 | 44,34 | 44,58 | 43,30 | 43,36 | -2,61% | 2,89% | 7.953.062 |
| 14/08/1997 | 44,58 | 45,00 | 44,28 | 44,52 | +0,74% | 1,61% | 9.835.270 |
| 13/08/1997 | 45,09 | 45,21 | 43,65 | 44,19 | -1,07% | 3,44% | 12.801.530 |
| 12/08/1997 | 45,44 | 45,68 | 44,61 | 44,67 | -1,71% | 2,36% | 9.516.469 |
| 11/08/1997 | 46,52 | 46,58 | 45,32 | 45,44 | -3,61% | 2,69% | 9.906.744 |
| 08/08/1997 | 47,38 | 47,95 | 46,79 | 47,14 | -0,94% | 2,45% | 6.576.619 |
| 07/08/1997 | 49,14 | 49,26 | 47,53 | 47,59 | -2,21% | 3,52% | 8.826.466 |
| 06/08/1997 | 48,78 | 48,96 | 48,54 | 48,66 | -0,97% | 0,86% | 4.835.891 |
| 05/08/1997 | 48,96 | 49,59 | 48,66 | 49,14 | -0,12% | 1,89% | 4.158.674 |
| 04/08/1997 | 48,66 | 49,29 | 48,52 | 49,20 | +0,61% | 1,59% | 3.957.248 |
| 01/08/1997 | 49,59 | 49,83 | 48,46 | 48,90 | -1,32% | 2,77% | 4.068.336 |
| 31/07/1997 | 49,71 | 50,01 | 49,23 | 49,56 | -0,12% | 1,56% | 3.313.147 |
| 30/07/1997 | 49,26 | 49,71 | 49,08 | 49,62 | +1,22% | 1,27% | 3.934.192 |
| 29/07/1997 | 47,92 | 49,08 | 47,89 | 49,02 | +2,11% | 2,49% | 4.131.635 |
| 28/07/1997 | 49,44 | 49,74 | 47,92 | 48,01 | -2,31% | 3,68% | 4.674.709 |
| 25/07/1997 | 49,53 | 50,36 | 48,31 | 49,14 | -0,72% | 4,15% | 7.264.526 |
| 24/07/1997 | 49,62 | 49,65 | 48,96 | 49,50 | -0,90% | 1,38% | 5.733.818 |
| 23/07/1997 | 50,90 | 51,05 | 49,86 | 49,95 | -1,41% | 2,34% | 6.911.979 |
| 22/07/1997 | 49,89 | 50,84 | 49,35 | 50,66 | +1,49% | 2,99% | 5.621.053 |
| 21/07/1997 | 50,42 | 50,45 | 49,53 | 49,92 | -1,65% | 1,83% | 5.681.208 |
| 18/07/1997 | 51,05 | 51,59 | 50,10 | 50,75 | -0,35% | 2,92% | 12.022.866 |
| 17/07/1997 | 47,23 | 51,62 | 47,20 | 50,93 | +8,38% | 9,34% | 19.718.539 |
| 16/07/1997 | 47,77 | 47,77 | 46,82 | 46,99 | -2,05% | 2,00% | 8.166.016 |
| 15/07/1997 | 48,19 | 48,22 | 47,32 | 47,98 | -0,06% | 1,86% | 5.116.546 |
| 14/07/1997 | 48,54 | 48,90 | 47,47 | 48,01 | -0,86% | 2,95% | 3.940.690 |
| 11/07/1997 | 48,04 | 48,81 | 48,01 | 48,43 | +1,00% | 1,68% | 4.072.528 |
| 10/07/1997 | 48,40 | 48,84 | 47,80 | 47,95 | -0,68% | 2,16% | 5.822.898 |
| 09/07/1997 | 49,62 | 49,77 | 48,01 | 48,28 | -2,65% | 3,55% | 6.520.656 |